GeoVax Company

GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.
Technology: Viral Vectors
Industry: Viral Vectors
Headquarters: Smyrna, Georgia, United States
Founded Date: 1988-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 1
Total Funding: 28048841
Estimated Revenue: Less than $1M
Last Funding Date: 2022-01-14
Last Funding Type: Post-IPO Equity

Visit Website
info@geovax.com
https://www.twitter.com/geovax_news
Register and Claim Ownership